PT Hetzer Medical Indonesia Tbk (IDX:MEDS)

IDX:MEDS Statistics

Total Valuation

IDX:MEDS has a market cap or net worth of IDR 120.31 billion. The enterprise value is 127.53 billion.

Market Cap	120.31B
Enterprise Value	127.53B

Important Dates

The last earnings date was Thursday, April 30, 2026.

Earnings Date	Apr 30, 2026
Ex-Dividend Date	n/a

Share Statistics

IDX:MEDS has 1.56 billion shares outstanding.

Current Share Class	1.56B
Shares Outstanding	1.56B
Shares Change (YoY)	n/a
Shares Change (QoQ)	n/a
Owned by Insiders (%)	58.64%
Owned by Institutions (%)	n/a
Float	646.22M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	18.15
PB Ratio	2.49
P/TBV Ratio	2.49
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	-15.28
EV / Sales	19.24
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	-46.69

Financial Position

The company has a current ratio of 1.17, with a Debt / Equity ratio of 0.17.

Current Ratio	1.17
Quick Ratio	0.17
Debt / Equity	0.17
Debt / EBITDA	n/a
Debt / FCF	-2.93
Interest Coverage	-12.29

Financial Efficiency

Return on equity (ROE) is -15.91% and return on invested capital (ROIC) is -14.64%.

Return on Equity (ROE)	-15.91%
Return on Assets (ROA)	-8.14%
Return on Invested Capital (ROIC)	-14.64%
Return on Capital Employed (ROCE)	-16.74%
Weighted Average Cost of Capital (WACC)	10.43%
Revenue Per Employee	414.32M
Profits Per Employee	-521.63M
Employee Count	16
Asset Turnover	0.10
Inventory Turnover	0.53

Taxes

Income Tax	-221.90M
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +54.00% in the last 52 weeks. The beta is 1.17, so IDX:MEDS's price volatility has been higher than the market average.

Beta (5Y)	1.17
52-Week Price Change	+54.00%
50-Day Moving Average	68.46
200-Day Moving Average	67.96
Relative Strength Index (RSI)	58.95
Average Volume (20 Days)	86,940,280

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, IDX:MEDS had revenue of IDR 6.63 billion and -8.35 billion in losses. Loss per share was -5.34.

Revenue	6.63B
Gross Profit	368.02M
Operating Income	-8.27B
Pretax Income	-8.57B
Net Income	-8.35B
EBITDA	-4.32B
EBIT	-8.27B
Loss Per Share	-5.34

Balance Sheet

The company has 779.02 million in cash and 8.00 billion in debt, with a net cash position of -7.22 billion or -4.62 per share.

Cash & Cash Equivalents	779.02M
Total Debt	8.00B
Net Cash	-7.22B
Net Cash Per Share	-4.62
Equity (Book Value)	48.30B
Book Value Per Share	30.91
Working Capital	2.13B

Cash Flow

In the last 12 months, operating cash flow was -1.48 billion and capital expenditures -1.26 billion, giving a free cash flow of -2.73 billion.

Operating Cash Flow	-1.48B
Capital Expenditures	-1.26B
Depreciation & Amortization	3.95B
Net Borrowing	1.32B
Free Cash Flow	-2.73B
FCF Per Share	-1.75

Margins

Gross margin is 5.55%, with operating and profit margins of -124.76% and -125.90%.

Gross Margin	5.55%
Operating Margin	-124.76%
Pretax Margin	-129.25%
Profit Margin	-125.90%
EBITDA Margin	-65.18%
EBIT Margin	-124.76%
FCF Margin	n/a

Dividends & Yields

IDX:MEDS does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	n/a
Shareholder Yield	n/a
Earnings Yield	-6.94%
FCF Yield	-2.27%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

IDX:MEDS has an Altman Z-Score of 3.47 and a Piotroski F-Score of 2.

Altman Z-Score	3.47
Piotroski F-Score	2